CNS Pharmaceuticals Inc

CNSP

Company Profile

  • Business description

    CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

  • Contact

    2100 West Loop South
    Suite 900
    HoustonTX77027
    USA

    T: +1 800 946-9185

    https://www.cnspharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    3

Stocks News & Analysis

stocks

10 of the cheapest global companies with wide moats

These undervalued stocks of high-quality companies could be attractive investments today.
stocks

Bookworm: Buy and hold inspiration from an unlikely source

Ben Graham was the king of flipping deep value stocks. The best investment of his life came from something very different.
stocks

3 ASX shares to avoid

These shares have surged in price in the last year but are significantly overvalued according to our analysts. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,082.1068.800.86%
CAC 408,053.0824.800.31%
DAX 4023,057.1770.350.31%
Dow JONES (US)41,488.19674.621.65%
FTSE 1008,643.4811.150.13%
HKSE24,145.57185.590.77%
NASDAQ17,754.09451.072.61%
Nikkei 22537,396.52343.420.93%
NZX 50 Index12,166.14100.11-0.82%
S&P 5005,638.94117.422.13%
S&P/ASX 2007,854.1064.400.83%
SSE Composite Index3,426.136.570.19%

Market Movers